- Home
- WSBF vs CVRX Comparison
WSBF vs CVRX Comparison
Compare WSBF & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSBF
- CVRX
- Stock Information
- Founded
- WSBF 1921
- CVRX 2000
- Country
- WSBF United States
- CVRX United States
- Employees
- WSBF N/A
- CVRX N/A
- Industry
- WSBF Savings Institutions
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- WSBF Finance
- CVRX Health Care
- Exchange
- WSBF Nasdaq
- CVRX Nasdaq
- Market Cap
- WSBF 240.7M
- CVRX 202.8M
- IPO Year
- WSBF N/A
- CVRX 2021
- Fundamental
- Price
- WSBF $12.92
- CVRX $6.64
- Analyst Decision
- WSBF
- CVRX Buy
- Analyst Count
- WSBF 0
- CVRX 7
- Target Price
- WSBF N/A
- CVRX $14.50
- AVG Volume (30 Days)
- WSBF 49.7K
- CVRX 516.1K
- Earning Date
- WSBF 07-24-2025
- CVRX 05-08-2025
- Dividend Yield
- WSBF 4.63%
- CVRX N/A
- EPS Growth
- WSBF 95.86
- CVRX N/A
- EPS
- WSBF 1.02
- CVRX N/A
- Revenue
- WSBF $133,551,000.00
- CVRX $52,870,000.00
- Revenue This Year
- WSBF N/A
- CVRX $13.92
- Revenue Next Year
- WSBF N/A
- CVRX $19.89
- P/E Ratio
- WSBF $12.70
- CVRX N/A
- Revenue Growth
- WSBF 1.81
- CVRX 25.62
- 52 Week Low
- WSBF $11.61
- CVRX $4.30
- 52 Week High
- WSBF $16.86
- CVRX $18.55
- Technical
- Relative Strength Index (RSI)
- WSBF 56.87
- CVRX 46.55
- Support Level
- WSBF $12.49
- CVRX $6.08
- Resistance Level
- WSBF $12.90
- CVRX $7.17
- Average True Range (ATR)
- WSBF 0.26
- CVRX 0.59
- MACD
- WSBF 0.04
- CVRX 0.18
- Stochastic Oscillator
- WSBF 63.53
- CVRX 81.37
About WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the Community Banking segment.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.